FMR1 CGG repeat numbers are reported:
Normal: <50 repeats Accurate sizing for alleles >90 repeats is not possible. See Interpretation. |
Hospital visiting guidelines updated 20 July 2022: Hospital visitors must wear a surgical/medical paper mask. Fabric face coverings are no longer acceptable. See our COVID-19 pages for detailed information about hospital visiting guidelines, COVID-19 tests and care in the community advice. See www.vaccinatecanterburywestcoast.nz for information about vaccinations.
We are at ORANGE according to the NZ COVID-19 Protection Framework
Last updated:
9th April 2022
Kia whakahaumaru te whānau, me ngā iwi katoa – this is to keep everybody safe:
By sticking to the rules above, you help keep our patients, staff, other visitors and yourself safe. We thank you in advance for your patience and understanding as our staff work hard to protect and care for some of the most vulnerable in our community.
Exceptions to the ‘one visitor’ policy
Visiting patients with COVID-19
You must NOT visit the hospital if you
Exceptions for people with disabilities
An exception will be made for people with disabilities who are in hospital or have to attend an outpatient appointment – where they need a support person to access health services. For example, a sign language interpreter, support person for someone with a learning disability, or someone to assist with mobility. The support person is in addition to the one permitted visitor.
Everyone visiting our facilities must wear a mask, no exceptions
While we appreciate that some people have legitimate reasons for being exempt from wearing a mask and may even have an official card to confirm this, people who cannot or will not wear a mask cannot visit someone in hospital or attend hospital, other than to access healthcare. This is another measure to minimise the risk to vulnerable patients.
Patients and visitors should also read the additional more detailed visiting guidelines for each specific hospital.
More COVID-19 information
The classic fragile X syndrome phenotype is male mental retardation to varying degrees, mild dysmorphic (abnormal-appearing) features, and enlargement of the testes in adults. Female heterozygotes may also be affected, depending on the pattern of X-inactivation in the brain.
Genetics - Molecular Pathology
MOLP
FMR1 CGG repeat
FXTAS
POF
Premature ovarian failure
4 weeks
5138
4.0
1
1.0
0.5
This genetic analysis requires nucleated cells. Please don’t centrifuge or freeze the EDTA blood tube.
If storing blood tube prior to delivery please refrigerate at 4 degrees (transport still at ambient temperature).
Ambient (8 - 24 degrees Celsius)
This genetic analysis requires nucleated cells. Please don’t centrifuge or freeze the EDTA blood tube.
If storing blood tube prior to delivery please refrigerate at 4 degrees (transport still at ambient temperature).
CGG repeats of normal, intermediate and low premutation size are amplified in the standard PCR. Normal males are identified by the presence of an allele with less than 58 CGG repeats. Premutations up to about 90 repeats are detectable. Females heterozygous for two normal alleles are also identified however about one-third of normal females are homozygous and are indistinguishable from fragile-X carriers in the standard PCR assay. These females, as well as the minority of samples which fail to amplify are re-analysed by triplet repeat primed PCR (TP-PCR) which reliably detects expanded CGG repeats in the 100 to >1000 repeat range but does not determine
repeat number.
FMR1 CGG repeat numbers are reported:
Normal: <50 repeats Accurate sizing for alleles >90 repeats is not possible. See Interpretation. |
Fluorescently tagged PCR fragments from the FMR1 CGG repeat region at Xq27.3 are accurately sized on the ABI3130xl Genetic Analyser. Triplet repeat primed PCR (TP-PCR) may be employed in some cases to detect large CGG expansions.
$224.45 (Exclusive of GST)
5138
Uncertainty of Measurement:
The PCR assay has an uncertainty of measurement of one repeat unit within the normal and intermediate size ranges, verified by testing the NIST fragile X Standard Reference Material PN2399.